Over 13 million US adults aged 50-59 years have a medical condition that increases their risk of severe RSV outcomes1 Clinical development programme continues to.
Over 13 million US adults aged 50-59 years have a medical condition that increases their risk of severe RSV outcomes1
Clinical development program continues to evaluate safety and immunogenicity.
HC Wainwright reaffirmed their buy rating on shares of Agenus (NASDAQ:AGEN – Free Report) in a research report released on Friday, Benzinga reports. HC Wainwright currently has a $40.00 price target on the biotechnology company’s stock. Other equities research analysts have also recently issued research reports about the stock. StockNews.com began coverage on shares of […]
HC Wainwright reiterated their buy rating on shares of Agenus (NASDAQ:AGEN – Free Report) in a research report released on Friday morning, Benzinga reports. HC Wainwright currently has a $40.00 price objective on the biotechnology company’s stock. AGEN has been the subject of a number of other reports. B. Riley reduced their price objective on […]
Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.